Literature DB >> 14350468

Fatal toxic encephalitis occurring during iproniazid therapy in pulmonary tuberculosis.

R S MITCHELL.   

Abstract

Entities:  

Keywords:  ENCEPHALITIS/etiology and pathogenesis; NICOTINIC ACID ISOMERS/poisoning; TUBERCULOSIS, PULMONARY/therapy

Mesh:

Substances:

Year:  1955        PMID: 14350468     DOI: 10.7326/0003-4819-42-2-417

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  15 in total

Review 1.  Serotonin syndrome and drug combinations: focus on MAOI and RIMA.

Authors:  S E Hilton; H Maradit; H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  Toxic effects of iproniazid in a patient with angina.

Authors:  C PAPP; S BENAIM
Journal:  Br Med J       Date:  1958-11-01

3.  Jaundice associated with administration of iproniazid; report of two cases.

Authors:  S BENAIM; M F DIXON
Journal:  Br Med J       Date:  1958-11-01

4.  Dangerous potentiation of pethidine by iproniazid, and its treatment.

Authors:  J C SHEE
Journal:  Br Med J       Date:  1960-08-13

5.  Psychosis due to isoniazid.

Authors:  S L JACKSON
Journal:  Br Med J       Date:  1957-09-28

6.  The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder.

Authors:  Lois Jessen; Lawrence J Kovalick; Albert J Azzaro
Journal:  P T       Date:  2008-04

Review 7.  Monoamine oxidase inhibitors revisited.

Authors:  D G Wells; A R Bjorksten
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

8.  Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers.

Authors:  Rui Tao; Mary Rudacille; Gongliang Zhang; Zhiyuan Ma
Journal:  Neuropsychopharmacology       Date:  2014-02-28       Impact factor: 7.853

9.  The role of 5-hydroxytryptamine and noradrenaline in the hyperthermic reaction induced by pethidine in rabbits pretreated with pargyline.

Authors:  I Fahim; M Ismail; O H Osman
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

Review 10.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.